FDA Guidance for ABSSSI Trials: Implications for Conducting and Interpreting Clinical Trials

Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections

(2013) Philippe Prokocimer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

CANVAS 1 and 2: Analysis of Clinical Response at Day 3 in Two Phase 3 Trials of Ceftaroline Fosamil versus Vancomycin plus Aztreonam in Treatment of Acute Bacterial Skin and Skin Structure Infections

(2012) H. David Friedland et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Collaborative Model for Endpoint Development for Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia

(2012) J. G. Toerner et al.   CLINICAL INFECTIOUS DISEASES

Progress on Developing Endpoints for Registrational Clinical Trials of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections: Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health

(2012) George H. Talbot et al.   CLINICAL INFECTIOUS DISEASES

Early response of ceftaroline fosamil in the treatment of soft-tissue infections

(2012) Christopher Giuliano et al.   Expert Review of Clinical Pharmacology

New Rules for Clinical Trials of Patients With Acute Bacterial Skin and Skin-Structure Infections: Do Not Let the Perfect Be the Enemy of the Good

(2011) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Through the looking glass: understanding non-inferiority

(2011) Jennifer Schumi et al.   Trials

Equivalence and Noninferiority Testing in Anesthesiology Research

(2010) Edward J. Mascha   ANESTHESIOLOGY

Skin and Soft‐Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship

(2010) Timothy C. Jenkins et al.   CLINICAL INFECTIOUS DISEASES

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Agents for Complicated Skin and Skin‐Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo‐Controlled Trials

(2009) Brad Spellberg et al.   CLINICAL INFECTIOUS DISEASES

Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms

(2008) Martin E. Stryjewski et al.   CLINICAL INFECTIOUS DISEASES